<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Shares of COVID-19 vaccine company Moderna, Inc. (NASDAQ: MRNA), which ended Thursday’s session with a market cap of $104.3 billion by virtue of a 5.28% rally, are seeing follow-through buying interest Friday. Standard & Poor’s announced late Thursday Moderna will join the S&P 500 Index, effective before the market opens Wednesday, July 21.
...read full article on Benzinga
